← FDA Drug Approvals (Drugs@FDA)
LIBERVANT
NDA · New Drug Application · Sponsor: AQUESTIVE · Approved 2022-08-30
Drug application
- FDA Application #
NDA212641- Application type
- New Drug Application
- Brand name
- LIBERVANT
- Generic name
- Diazepam
- Active ingredients
- DIAZEPAM
- Dosage form
- FILM
- Route
- BUCCAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AQUESTIVE
- First approval
- 2022-08-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown